SPX3,933.92-7.34 -0.19%
DIA336.44-0.02 -0.01%
IXIC10,958.55-56.34 -0.51%

AbbVie Gets Health Canada Approval for Ubrelvy Tablet to Treat Migraines

AbbVie Gets Health Canada Approval for Ubrelvy Tablet to Treat Migraines

MT Newswires · 11/16/2022 07:23

Please log in to view news